Success Stories: With NAILG’s Expert RFE Response, EB1A Approved for Biomedical Engineering Lecturer
Client’s Testimonial:
“Thank you for your message! This is the best news I have received in a while! Thank you so much for your team's hard and excellent work!”
On April 21st, 2025, we received another EB-1A (Alien of Extraordinary Ability) approval for a Lecturer in the Field of Biomedical Engineering (Approval Notice).
General Field: Biomedical Engineering
Position at the Time of Case Filing: Lecturer
Country of Origin: China
Country of Residence at the Time of Filing: China
Approval Notice Date: April 21st, 2025
Processing Time: 3 months, 22 days (Premium Processing Requested)
Case Summary:
A trailblazer in biomedical engineering has received EB1A approval for his outstanding scientific contributions in the design, synthesis, and application of nanomaterials in healthcare, despite an initial Request for Evidence (RFE) issued by USCIS. Thanks to the strategic guidance of the North America Immigration Law Group (NAILG), his case was ultimately recognized as meeting the high bar of extraordinary ability in the field.
NAILG worked closely with him to strengthen the presentation of his petition following the RFE. They expertly framed his highly technical work for a legal audience, articulated the broader national and global significance of his innovations, and reinforced the exceptional metrics that distinguish him as a top researcher.
Our client’s research addresses several of the most pressing challenges in modern medicine, including the use of nano-graphene oxide for tumor phototherapy, the application of upconversion luminescent nanomaterials for advanced diagnostic and therapeutic strategies, and the evaluation of triplet-triplet annihilation nanocapsules to improve biocompatibility and reduce toxicity in nanomedical treatments.
These innovations have led to:
● 12 peer-reviewed journal articles, with 3 first- or co-first-authored;
● 2,446 citations, underscoring the global relevance and application of his findings;
● 30 completed peer reviews, indicating his respected standing in the academic community;
● And research funding from the National Natural Science Foundation of China (NSFC), reflecting the scientific merit and trust placed in his work.
As one expert recommender wrote:“To close, [client] has quickly risen to the forefront of biomedical engineering research due to his expertise in the design, synthesis, and application of nanomaterials such as upconversion nanocapsules in real-world settings. This has made him particularly well-suited to addressing the most pressing challenges in the healthcare industry, including the overall toxicity of triplet-triplet annihilation upconversion nanocapsules. It is therefore clear that [client] is a leader in the field of biomedical engineering.”
With NAILG’s tailored RFE strategy and comprehensive petition design, our client’s extraordinary ability was rightfully recognized. His approval ensures that he may continue his impactful research in the United States, bringing forward biomedical innovations that support safer, more efficient, and highly targeted healthcare solutions.